Y. Hattori

A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110).

M. Satouchi, T. Nishimura, S. Morita, 2015, Lung cancer.